Taro Pharmaceutical Industries Ltd reports results for the quarter ended in June - Earnings Summary

Taro Pharmaceutical Industries

27/07/2023 02:45

* Taro Pharmaceutical Industries Ltd  TARO.N  reported
quarterly
adjusted earnings of 40 cents​​ per share for the quarter ended
in June. The lone analyst forecast for the quarter was
for earnings of 31 cents per share.
    * Revenue rose 1.4% to $158.89 million from a year ago;
analysts
expected $149.03 million. 
    * Taro Pharmaceutical Industries Ltd's reported EPS for the
quarter was 27 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Taro Pharmaceutical Industries Ltd shares had fallen
by 2.7%
this quarter and gained 27.1% so far this year.
    * The company reported quarterly net income of $10.03
million.
    * Wall Street's median 12-month price target for Taro
Pharmaceutical Industries Ltd is $35.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data July
27 at 01:44 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.31           0.40           Beat
 Mar. 31 2023      0.23           0.18           Missed
 Dec. 31 2022      0.87           0.19           Missed
 Sep. 30 2022      0.84           -0.07          Missed